where to do tirzepatide injections and How Inject Tirzepatide: Step-by-Step Guide Guide to Tirzepatide: What to

The analysis is based on tirzepatide eligibility criteria and results from the SURMOUNT-1 trial, published in 2022 in The New England Journal of Medicine , which showed that tirzepatide, approved last year by the FDA for the treatment of obesity, reduced body weight up to an average of 21% on the highest 15-milligram dosages along with reductions in several cardiovascular risk factors such as blood pressure and cholesterol

Our specialists will work with you to determine the best course of treatment based on your preferences and medical history, ensuring that you get the most effective support for your health goals

A 10 mg/mL vial requires different unit math than a 20 mg/mL vial

Our experience shows that patients who understand this from the outset feel more confident and empowered